Remove Marketing Remove Pharma Production Remove Trials
article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Pharma websites need disruption

World of DTC Marketing

Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. In the past, pharma product websites had a huge effect on whether a patient asks for an Rx. 5ive: It’s time to update clinical trial information. Want proof? 3d render ).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unfair balance

World of DTC Marketing

When online health seekers come to a pharma product website they want to know “what’s in it for me?” ” and “how much the drug costs” Sure, they will go to the product safety information page but it’s too hard for them to comprehend. It’s a huge waste of space, money, and time.

article thumbnail

Elements of a great pharma website

World of DTC Marketing

In clinical trials, how many people experienced a listed side effect? Email is still a great digital marketing tool, and our audiences felt that if the email contained updated health information and tips for living with certain health problems, they would open and read it. First impressions are 94% design-related.

Drugs 180
article thumbnail

Bayer triples sales forecast for prostate cancer drug Nubeqa

pharmaphorum

The optimistic assessment of the revenue potential for androgen receptor inhibitor Nubeqa (darolutamide) follows the publication of the results of the phase 3 ARASENS trial in the New England Journal of Medicine. compared to standard therapy alone.

Sales 98
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. My background for decades now is in the pharma marketing and branding space, working with all sorts of pharma products, devices, diagnostics. Do you connect patients with the clinical trial folks? Don (PMN): Wonderful.

Doctor 40